Ras-Rasayan tablets contain processed heavy metals and require strict GMP licensing, pharmacopoeial testing and complete documentation that every bulk buyer.
Ras-Rasayan tablets are among the most regulated products in the Ayurvedic category because they contain processed heavy metals and minerals. For any brand owner, distributor or exporter buying these in bulk, the documentation and certification a supplier provides is as important as the product itself. Cutting corners on supplier qualification creates compliance risks that are difficult to resolve after a shipment arrives.
Ras-Rasayan formulations are built on processed mercury, sulphur and other metals and minerals. While classical Ayurvedic texts and the Ayurvedic Pharmacopoeia of India describe the processing methods that render these materials pharmacologically appropriate for use, the category carries inherent regulatory sensitivity because inadequately processed heavy metals can cause harm. This makes the regulatory environment around Ras-Rasayan considerably stricter than it is for purely botanical Ayurvedic formulations.
In India, the Drugs and Cosmetics Act, 1940, and its Schedule T provisions require that Ras-Rasayan formulations are manufactured only in facilities holding an AYUSH manufacturing licence specifically covering this category. Each batch must be tested against Ayurvedic Pharmacopoeia of India specifications before release. These are not administrative requirements that can be waived or treated as paperwork. They are conditions of lawful supply, and a supplier who cannot produce current documentary evidence of compliance should not be considered for a commercial relationship.
For buyers operating outside India, the scrutiny intensifies further. Regulatory authorities in Europe, North America, Southeast Asia and the Gulf have varying requirements for imported products containing processed heavy metals. Some impose destination-specific heavy metal thresholds that differ from Ayurvedic Pharmacopoeia of India limits. Researching the destination market's requirements before placing a first order is a buyer responsibility that should not be deferred until after goods have shipped.
The minimum licensing a legitimate Ras-Rasayan bulk supplier in India must hold is an AYUSH manufacturing licence issued under the Drugs and Cosmetics Act, with a scope that specifically covers the Ras Rasayan category, and a GMP certificate under Schedule T. Both are issued by state drug authorities and are valid for renewable periods. Buyers should request copies of both documents at the supplier qualification stage and verify that the licence scope includes the specific product being ordered.
Licence scopes can be narrow and category-specific. A facility licensed to manufacture Vati, Churna or Taila is not automatically authorised to manufacture Ras Rasayan preparations. Checking the scope is a straightforward step that is sometimes omitted in the commercial rush to confirm a price and place an order, but it is a basic due diligence requirement for this category.
Raasa Ayurveda holds GMP certificate D-5755/09 and AYUSH manufacturing licence A-4177/2009, and offers 53 Ras-Rasayan preparations from its classical Shastrayoga range. Copies of the licence and GMP certificate are provided as a standard part of the supplier qualification process.
The certificate of analysis for a Ras-Rasayan tablet should cover all test parameters prescribed in the Ayurvedic Pharmacopoeia of India for the specific formulation. Beyond the standard pharmacopoeial tests, buyers should specifically look for reported results on the principal metals named in the formulation, such as mercury, iron or copper, along with limits for incidental contaminants including arsenic, lead and cadmium. These contaminant limits are not optional. They are pharmacopoeial requirements that protect both the end consumer and the brand owner.
Microbial limit testing is also required under Schedule T GMP and should appear on every certificate of analysis for an oral preparation. This is sometimes overlooked by buyers focused primarily on heavy metal content, but the tabletting process does not sterilise the product. Contamination originating from raw materials or the processing environment must be controlled and confirmed absent at the finished product stage before the batch is released.
If a buyer requires test coverage beyond the supplier's standard certificate, for example to satisfy a specific import standard in a destination market, this should be agreed with the supplier before production begins. A GMP-certified facility that regularly exports may already conduct additional testing as a standard matter, and confirming this in advance avoids the need to retest at destination.
A compliant bulk consignment of Ras-Rasayan tablets from a GMP-certified Indian manufacturer should be accompanied by a certificate of analysis covering all prescribed pharmacopoeial parameters for the batch, copies of the current AYUSH manufacturing licence and GMP certificate, and a batch record summary that identifies the formulation reference, the source and authenticated quantity of each ingredient and the processing stages completed including shodhana for any ingredients requiring purification.
For export, buyers typically also need a certificate of pharmaceutical product, phytosanitary documentation or destination-country-specific declarations depending on import requirements. These documents are not produced automatically by the manufacturer and require advance coordination. A buyer who raises documentation requirements at the sampling stage, before production is scheduled, is in a far stronger position than one who requests them after goods have already been dispatched.
Raasa Ayurveda provides a certificate of analysis with every consignment. Buyers should review the scope of that certificate at the sampling stage and raise any additional documentation needs before production is confirmed, so the complete package is ready when the goods are ready to ship.
No serious buyer of Ras-Rasayan tablets should commit to a large bulk order without a prior sampling and approval stage. This is standard practice in any regulated product category and it protects both parties by establishing a documented quality benchmark before scale-up to production quantities.
A structured sampling process involves requesting a sample of the exact formulation in the intended tablet form and packaging configuration, reviewing the certificate of analysis accompanying the sample, and if required, sending a portion to an accredited independent laboratory for confirmation testing against the Ayurvedic Pharmacopoeia of India specification. Any concerns raised by the independent test results should be discussed with the supplier and resolved before a purchase order is raised.
Buyers developing a branded Ras-Rasayan range through a contract manufacturing arrangement should also use the sampling stage to confirm label claim accuracy, tablet weight and dimensions, and packaging specifications. The bulk supply stage that follows will then be based on a clearly agreed specification, which reduces the likelihood of disputes or rejections after delivery.
Before placing a purchase order for Ras-Rasayan tablets, buyers should ask their prospective supplier the following. Does the AYUSH licence scope specifically cover Ras Rasayan preparations? Which classical text edition is used as the formulation reference? What is the complete ingredient list, and is the shodhana process for all applicable ingredients documented in batch records? What does the certificate of analysis cover, and can additional testing parameters be added if the buyer's market requires them? What packaging configurations are available, and can labelling requirements be accommodated?
Raasa Ayurveda's Kanpur facility has produced classical Ayurvedic formulations for seventeen years. To enquire about available Ras-Rasayan formulations, samples and documentation, write to raasaayurveda@gmail.com or phone +91 9415128217 and the team will guide you through the supplier qualification process.
A legitimate Ras-Rasayan supplier in India must hold an AYUSH manufacturing licence with a scope that specifically covers Ras Rasayan preparations, and a GMP certificate under Schedule T of the Drugs and Cosmetics Act. Buyers should request copies of both and verify the scope matches the product being ordered. A Vati or Churna licence does not automatically extend to Ras Rasayan.
The certificate should cover all Ayurvedic Pharmacopoeia of India test parameters for the formulation, including assay for named metals, limits for incidental contaminants such as arsenic, lead and cadmium, and microbial limit testing. If the standard certificate does not cover parameters required for a specific export market, additional testing should be arranged with the supplier before production commences.
Independent laboratory testing of samples before a bulk order is a sound practice for any Ras-Rasayan product. An accredited laboratory can confirm the product meets Ayurvedic Pharmacopoeia of India specifications and any additional standards required for the buyer's market. This step adds time to the sampling stage but reduces compliance risk and provides documentary evidence the buyer can use with their own customers.
Request a sample in the intended tablet form and packaging, review the certificate of analysis, and test through an independent laboratory if required. Resolve any specification questions before raising a purchase order. Also confirm documentation requirements for the destination market at this stage, so the full documentation package is prepared alongside the production batch and ready for shipment.
Raasa Ayurveda, 49/72-A, Naughara, Kanpur 208001, Uttar Pradesh, India. Telephone +91 9415128217. Email raasaayurveda@gmail.com.